Literature DB >> 9515829

Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients.

L P Boulet1.   

Abstract

BACKGROUND: Misunderstanding of the role of asthma medication and fear of untoward side effects may reduce compliance to therapy, potentially resulting in poor asthma control and increased risk of severe asthma events.
METHODS: We report the results of a recent Canadian survey of 603 asthmatic patients recruited from the general population, aimed at determining their perception of the role and potential side effects of inhaled corticosteroids (ICS).
RESULTS: The survey revealed that a large proportion of asthmatic patients do not understand the role of their medications and have many misconceptions and fears in regard to ICS, reducing their willingness to use them. Among the most common fears are those concerning troublesome side effects, particularly in regard to corporeal image, bone density, and a reduction in efficacy of medication over time. More than half of the population said they were very or somewhat concerned using ICS on a regular basis; two thirds of patients had not discussed their concerns about ICS with their physicians or other health-care professionals. Finally, in a large number of asthma patients, asthma was not adequately controlled, according to recent asthma consensus guidelines.
CONCLUSIONS: These observations stress the importance for those involved in asthma care of questioning patients about their understanding of the role of asthma medications, particularly ICS, their fears and misconceptions, and what they consider to be adequate asthma control, in order to provide appropriate education and counseling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515829     DOI: 10.1378/chest.113.3.587

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  38 in total

Review 1.  Low dose inhaled corticosteroids and the prevention of death from asthma.

Authors:  J C Kips; R A Pauwels
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Health literacy, language, and ethnicity-related factors in newcomer asthma patients to Canada: a qualitative study.

Authors:  Iraj Poureslami; Irving Rootman; Mary M Doyle-Waters; Laura Nimmon; J Mark Fitzgerald
Journal:  J Immigr Minor Health       Date:  2011-04

3.  Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study.

Authors:  J Mark FitzGerald; Louis-Philipe Boulet; R Andrew McIvor; Sabrina Zimmerman; Kenneth R Chapman
Journal:  Can Respir J       Date:  2006 Jul-Aug       Impact factor: 2.409

Review 4.  The paradox of adult asthma control: "who's in control anyway?".

Authors:  Rick Hodder
Journal:  Can Respir J       Date:  2007 May-Jun       Impact factor: 2.409

5.  Severe and uncontrolled asthma in China: a cross-sectional survey from the Australasian Severe Asthma Network.

Authors:  Gang Wang; Fang Wang; Peter G Gibson; Michael Guo; Wei-Jie Zhang; Peng Gao; Hong-Ping Zhang; Erin S Harvey; Hui Li; Jie Zhang
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

6.  Exploring variables associated with medication non-adherence in patients with COPD.

Authors:  Anan S Jarab; Tareq L Mukattash
Journal:  Int J Clin Pharm       Date:  2019-08-30

7.  A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/formoterol Turbuhaler (160/4.5 μg/d) with Twice-daily Budesonide (400 μg/d) During the Step-down Period in Well-controlled Asthma.

Authors:  Narongwit Nakwan; Thitima Perkleang; Thanida Tamsawai; Pattarawadee Taptawee; Sirikade Usaha
Journal:  Turk Thorac J       Date:  2018-04-01

8.  The CASE survey: patient and physician perceptions regarding asthma medication use and associated oropharyngeal symptoms.

Authors:  J M Fitzgerald; C Kn Chan; M C Holroyde; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2008 Jan-Feb       Impact factor: 2.409

9.  Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.

Authors:  David Price; Anne Robertson; Kevin Bullen; Cynthia Rand; Rob Horne; Heribert Staudinger
Journal:  BMC Pulm Med       Date:  2010-01-05       Impact factor: 3.317

Review 10.  Does route of administration affect the outcome of TNF antagonist therapy?

Authors:  Sergio Schwartzman; G James Morgan
Journal:  Arthritis Res Ther       Date:  2004-06-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.